Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Alcoa World Alumina and Chemicals (AWAC) is a global enterprise that operates as a major producer of bauxite and alumina. Originally established as a joint venture between Alcoa and Alumina Limited, the company manages a vast network of mines and refineries across Australia, Brazil, Spain, Saudi Arabia, and Guinea. Its primary business involves the extraction of bauxite ore and its subsequent refinement into alumina, the critical feedstock for aluminum smelting. In August 2024, Alcoa completed the acquisition of Alumina Limited, consolidating AWAC's assets entirely under Alcoa's corporate umbrella. While the company is not a biotechnology or pharmaceutical firm, its chemical products are utilized in various industrial applications, including the production of medical-grade ceramics and vaccine adjuvants.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Alcoa World Alumina and Chemicals.